Evidence map›Paper›PMID 15922739›Full record

ArticleExperimental cell research2005

Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity.

Yoshihiro Nishida, Warren Knudson, Cheryl B Knudson, Naoki Ishiguro

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 65 citations in OpenAlex.

  1. Hyaluronic Acid as a Modern Approach in Anticancer Therapy-Review.International journal of molecular sciences · 2022
    Review
  2. Article
  3. Article
  4. Review
  5. The role of extracelluar matrix in osteosarcoma progression and metastasis.Journal of experimental & clinical cancer research : CR · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yoshihiro NishidaDepartment of Orthopaedic Surgery, Nagoya University School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan. ynishida@med.nagoya-u.ac.jp
Warren Knudson
Cheryl B Knudson
Naoki Ishiguro
Nagoya University · JPRush University Medical Center · US

Funding

SPECIALIZED CENTER OF RESEARCH IN OSTEOARTHRITISP50AR039239 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI OEGEMA, THEODORE RICHARD · 1987 to 2007
$8.5M
HYALURONAN-CELL INTERACTIONS IN CARTILAGER01AR039507 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI KNUDSON, CHERYL B · 1998 to 2013
$3.1M
CD44 MEDIATED CATABOLISM OF HYALURONAN BY CHONDROCYTESR01AR043384 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI KNUDSON, WARREN · 1996 to 2009
$2.7M
NIAMS NIH HHS P50 AR039239NIAMS NIH HHS P50-AR39239NIAMS NIH HHS R01 AR039507NIAMS NIH HHS R01 AR043384NIAMS NIH HHS R01-AR39507NIAMS NIH HHS R01-AR43384
6 · The paper itself

Abstract

Osteosarcoma is a common malignant bone tumor associated with childhood and adolescence. The results of numerous studies have suggested that hyaluronan plays an important role in regulating the aggressive behavior of various types of cancer cells. However, no studies have addressed hyaluronan with respect to osteosarcomas. In this investigation, the mRNA expression copy number of three mammalian hyaluronan synthases (HAS) was determined using competitive RT-PCR in the osteoblastic osteosarcoma cell line, MG-63. MG-63 are highly malignant osteosarcoma cells with an abundant hyaluronan-rich matrix. The results demonstrated that HAS-2 is the predominant HAS in MG-63. Accumulation of intracellular hyaluronan increased in association with the proliferative phase of these cells. The selective inhibition of HAS-2 mRNA in MG-63 cells by antisense phosphorothioate oligonucleotides resulted in reduced hyaluronan accumulation by these cells. As expected, the reduction in hyaluronan disrupted the assembly of cell-associated matrices. However, of most interest, coincident with the reduction in hyaluronan, there was a substantial decrease in cell proliferation, a decrease in cell motility and a decrease in cell invasiveness. These data suggest that hyaluronan synthesized by HAS-2 in MG-63 plays a crucial role in osteosarcoma cell proliferation, motility, and invasion.

Indexed as

Bone NeoplasmsCell Line, TumorCell MovementCell ProliferationChemotaxisCollagenDrug CombinationsGene DosageGlucuronosyltransferaseHumansHyaluronan SynthasesHyaluronic AcidKineticsLamininOligonucleotides, AntisenseOsteosarcomaCollagenDrug CombinationsGlucuronosyltransferaseHyaluronan SynthasesHyaluronic AcidLamininmatrigelOligonucleotides, AntisenseProteoglycansRNA, Messenger

Identifiers

PMID15922739
PMCPMC3182490
OpenAlexW2076359157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.